
    
      Early stage liver cancer, according to Milan criteria, are chose for this study. The patients
      are divided into two groups randomly. Patients in group A receive laparoscopic hepatectomy,
      group B patients receive SBRT.The 3-year progression free survival, 3-year local recurrence
      free survival, 3- year overall survival and other endpoints events were recorded and
      analyzed, to assess whether SBRT is non-inferior to surgery.
    
  